-
2
-
-
0036546297
-
The prevalence of thrombophilia in patients with chronic venous leg ulceration
-
MacKenzie R.K., Ludlam C.A., Ruckley C.V., Allan P.L., Burns P., and Bradbury A.W. The prevalence of thrombophilia in patients with chronic venous leg ulceration. J Vasc Surg 35 (2002) 718-722
-
(2002)
J Vasc Surg
, vol.35
, pp. 718-722
-
-
MacKenzie, R.K.1
Ludlam, C.A.2
Ruckley, C.V.3
Allan, P.L.4
Burns, P.5
Bradbury, A.W.6
-
3
-
-
0242408365
-
The prevalence of hyperhomocysteinaemia, methylene tetrahydrofolate reductase C677T mutation, and vitamin B12 and folate deficiency in patients with chronic venous insufficiency
-
Sam R.C., Burns P.J., Hobbs S.D., Marshall T., Wilmink A.B.M., Silverman S.H., et al. The prevalence of hyperhomocysteinaemia, methylene tetrahydrofolate reductase C677T mutation, and vitamin B12 and folate deficiency in patients with chronic venous insufficiency. J Vasc Surg 38 (2003) 904-908
-
(2003)
J Vasc Surg
, vol.38
, pp. 904-908
-
-
Sam, R.C.1
Burns, P.J.2
Hobbs, S.D.3
Marshall, T.4
Wilmink, A.B.M.5
Silverman, S.H.6
-
4
-
-
0035082284
-
Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers
-
Gaber Y., Siemens H.J., and Schmeller W. Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers. Br J Dermatol 144 (2001) 546-548
-
(2001)
Br J Dermatol
, vol.144
, pp. 546-548
-
-
Gaber, Y.1
Siemens, H.J.2
Schmeller, W.3
-
5
-
-
0030928539
-
Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers
-
Grossman D., Heald P.W., Wang C., and Rinder H.M. Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers. J Am Acad Dermatol 37 (1997) 409-413
-
(1997)
J Am Acad Dermatol
, vol.37
, pp. 409-413
-
-
Grossman, D.1
Heald, P.W.2
Wang, C.3
Rinder, H.M.4
-
7
-
-
41949139088
-
Serum concentration of procoagulant, endothelial and oxidative stress markers in early primary varicose veins
-
Yasim A., Kilinc M., Aral M., Oksuz H., Kabalci M., Eroglu E., et al. Serum concentration of procoagulant, endothelial and oxidative stress markers in early primary varicose veins. Phlebology 23 (2008) 15-20
-
(2008)
Phlebology
, vol.23
, pp. 15-20
-
-
Yasim, A.1
Kilinc, M.2
Aral, M.3
Oksuz, H.4
Kabalci, M.5
Eroglu, E.6
-
8
-
-
19944392548
-
American Venous Forum International Ad Hoc Committee for the Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement
-
Eklof B., Rutherford R.B., Bergan J.J., Carpentier P.H., Gloviczki P., Kistner R.L., et al. American Venous Forum International Ad Hoc Committee for the Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 40 (2004) 1248-1252
-
(2004)
J Vasc Surg
, vol.40
, pp. 1248-1252
-
-
Eklof, B.1
Rutherford, R.B.2
Bergan, J.J.3
Carpentier, P.H.4
Gloviczki, P.5
Kistner, R.L.6
-
9
-
-
0029850530
-
A common genetic variation in the 3°Ç-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
-
Poort S.R., Rosendaal F.R., Reitsma P.H., and Bertina R.M. A common genetic variation in the 3°Ç-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88 (1996) 3698-3703
-
(1996)
Blood
, vol.88
, pp. 3698-3703
-
-
Poort, S.R.1
Rosendaal, F.R.2
Reitsma, P.H.3
Bertina, R.M.4
-
12
-
-
0030062677
-
Resistance to activated protein C: a common anticoagulant deficiency in patients with venous leg ulceration
-
Munkvad S., and Jorgensen M. Resistance to activated protein C: a common anticoagulant deficiency in patients with venous leg ulceration. Br J Dermatol 134 (1996) 296-298
-
(1996)
Br J Dermatol
, vol.134
, pp. 296-298
-
-
Munkvad, S.1
Jorgensen, M.2
-
13
-
-
0031472653
-
Resistance to activated protein C in patients with venous leg ulcers
-
Hafner J., and von Felten A. Resistance to activated protein C in patients with venous leg ulcers. Dermatology 195 (1997) 413-414
-
(1997)
Dermatology
, vol.195
, pp. 413-414
-
-
Hafner, J.1
von Felten, A.2
-
14
-
-
0032930881
-
The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiency
-
Maessen-Visch M.B., Hamulyak K., Tazelaar D.J., Crombag N.H., and Neumann H.A. The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiency. Arch Dermatol 135 (1999) 41-44
-
(1999)
Arch Dermatol
, vol.135
, pp. 41-44
-
-
Maessen-Visch, M.B.1
Hamulyak, K.2
Tazelaar, D.J.3
Crombag, N.H.4
Neumann, H.A.5
-
15
-
-
0032769126
-
A prospective coagulation study including resistance to activated protein C and mutations in factors V and II in venous leg ulcers
-
Ribeaudeau F., Senet P., Cavuela J.M., Fund X., Paul C., Robert C., et al. A prospective coagulation study including resistance to activated protein C and mutations in factors V and II in venous leg ulcers. Br J Dermat 141 (1999) 259-263
-
(1999)
Br J Dermat
, vol.141
, pp. 259-263
-
-
Ribeaudeau, F.1
Senet, P.2
Cavuela, J.M.3
Fund, X.4
Paul, C.5
Robert, C.6
-
16
-
-
0033519051
-
Venous thrombosis: a multicausal disease
-
Rosendaal F.R. Venous thrombosis: a multicausal disease. Lancet 353 (1999) 1167-1173
-
(1999)
Lancet
, vol.353
, pp. 1167-1173
-
-
Rosendaal, F.R.1
-
17
-
-
0032589083
-
Leg ulcers and antiphospholipid antibodies. Prospective study of 48 cases
-
Alcaraz I., Levfevre I., Wiart T., Lafon C., Forzy G., and Modiano P. Leg ulcers and antiphospholipid antibodies. Prospective study of 48 cases. Ann Dermatol Venereol 126 (1999) 313-316
-
(1999)
Ann Dermatol Venereol
, vol.126
, pp. 313-316
-
-
Alcaraz, I.1
Levfevre, I.2
Wiart, T.3
Lafon, C.4
Forzy, G.5
Modiano, P.6
-
18
-
-
0036203183
-
Lupus anticoagulant and venous leg ulceration
-
Fink A., Kottas-Heldenberg A., Mayer W., Partsch H., Bayer P., Bednar R., et al. Lupus anticoagulant and venous leg ulceration. Br J Dermatol 146 (2002) 308-310
-
(2002)
Br J Dermatol
, vol.146
, pp. 308-310
-
-
Fink, A.1
Kottas-Heldenberg, A.2
Mayer, W.3
Partsch, H.4
Bayer, P.5
Bednar, R.6
-
19
-
-
0028851046
-
Prevalence of protein C deficiency in the healthy population
-
Tait R.C., Walker I.D., Reitsma P.H., Islam S.I., McCall F., Poort S.R., et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 73 (1995) 87-93
-
(1995)
Thromb Haemost
, vol.73
, pp. 87-93
-
-
Tait, R.C.1
Walker, I.D.2
Reitsma, P.H.3
Islam, S.I.4
McCall, F.5
Poort, S.R.6
-
20
-
-
0025034110
-
Protein C and protein S plasma levels in patients with lipodermatosclerosis and venous ulceration
-
Falanga V., Bontemo F.A., and Eaglstein W.H. Protein C and protein S plasma levels in patients with lipodermatosclerosis and venous ulceration. Arch Dermatol 126 (1990) 1195-1197
-
(1990)
Arch Dermatol
, vol.126
, pp. 1195-1197
-
-
Falanga, V.1
Bontemo, F.A.2
Eaglstein, W.H.3
-
21
-
-
0034833989
-
The importance of hyperhomocysteinaemia as a risk factor for disease: an overview
-
Herrmann W. The importance of hyperhomocysteinaemia as a risk factor for disease: an overview. Clin Chem Lab Med 39 (2001) 666-674
-
(2001)
Clin Chem Lab Med
, vol.39
, pp. 666-674
-
-
Herrmann, W.1
-
22
-
-
0030299976
-
Hyperhomocysteinaemia and deep-vein thrombosis: a case-control study
-
Simioni P., Prandoni P., Burlina A., Tormene D., Sardella C., Ferrari V., et al. Hyperhomocysteinaemia and deep-vein thrombosis: a case-control study. Thromb Haemost 76 (1996) 883-886
-
(1996)
Thromb Haemost
, vol.76
, pp. 883-886
-
-
Simioni, P.1
Prandoni, P.2
Burlina, A.3
Tormene, D.4
Sardella, C.5
Ferrari, V.6
-
23
-
-
0031733260
-
Hyperhomocysteinaemia and venous thrombosis: a meta-analysis
-
den Heijer M., Rosendaal F.R., Blom H.J., Gerrits W.B.J., and Bos G.M.J. Hyperhomocysteinaemia and venous thrombosis: a meta-analysis. Thromb Haemost 80 (1998) 874-877
-
(1998)
Thromb Haemost
, vol.80
, pp. 874-877
-
-
den Heijer, M.1
Rosendaal, F.R.2
Blom, H.J.3
Gerrits, W.B.J.4
Bos, G.M.J.5
-
24
-
-
0032569645
-
Meta-analysis of hyperhomocysteinaemia as a risk factor for venous thromboembolic disease
-
Ray J.G. Meta-analysis of hyperhomocysteinaemia as a risk factor for venous thromboembolic disease. Arch Int Med 158 (1998) 2101-2106
-
(1998)
Arch Int Med
, vol.158
, pp. 2101-2106
-
-
Ray, J.G.1
-
25
-
-
0036881491
-
Hyperhomocysteinaemia and thrombophilia
-
Key N.S., and McGlennen R.C. Hyperhomocysteinaemia and thrombophilia. Arch Pathol Lab Med 126 (2002) 1367-1375
-
(2002)
Arch Pathol Lab Med
, vol.126
, pp. 1367-1375
-
-
Key, N.S.1
McGlennen, R.C.2
-
26
-
-
0028945691
-
The effect of aspirin on haemostatic activity in the treatment of chronic venous ulceration
-
Ibbotson S.H., Layton A.M., Davies J.A., and Goodfield M.J. The effect of aspirin on haemostatic activity in the treatment of chronic venous ulceration. Br J Dermatol 132 (1995) 422-426
-
(1995)
Br J Dermatol
, vol.132
, pp. 422-426
-
-
Ibbotson, S.H.1
Layton, A.M.2
Davies, J.A.3
Goodfield, M.J.4
-
27
-
-
0028814316
-
Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis
-
Koster T., Blann A.D., Briet E., Vandenbroucke J.P., and Rosendaal F.R. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345 (1995) 152-155
-
(1995)
Lancet
, vol.345
, pp. 152-155
-
-
Koster, T.1
Blann, A.D.2
Briet, E.3
Vandenbroucke, J.P.4
Rosendaal, F.R.5
-
29
-
-
26944475548
-
The association between raised coagulation factor levels and venous thrombo-embolism
-
Sam R.C., Wong M., Adam D.J., Fegan C., Silverman S.H., and Bradbury A.W. The association between raised coagulation factor levels and venous thrombo-embolism. Eur J Vasc Endovasc Surg 30 (2005) 539-544
-
(2005)
Eur J Vasc Endovasc Surg
, vol.30
, pp. 539-544
-
-
Sam, R.C.1
Wong, M.2
Adam, D.J.3
Fegan, C.4
Silverman, S.H.5
Bradbury, A.W.6
-
30
-
-
0034680013
-
High plasma levels of factor VIII and the risk of recurrent venous thrombo-embolism
-
Kyrle P.A., Minar E., Hirschl M., Bialonczyk C., Stain M., Scneider B., Welterman A., Speiser W., Lechner K., and Eichinger S. High plasma levels of factor VIII and the risk of recurrent venous thrombo-embolism. N Engl J Med 343 (2000) 457-462
-
(2000)
N Engl J Med
, vol.343
, pp. 457-462
-
-
Kyrle, P.A.1
Minar, E.2
Hirschl, M.3
Bialonczyk, C.4
Stain, M.5
Scneider, B.6
Welterman, A.7
Speiser, W.8
Lechner, K.9
Eichinger, S.10
-
31
-
-
1242269966
-
High plasma levels of factor VIII and risk of recurrence of venous thromboembolism
-
Cristina L., Benilde C., Michela C., Mirella F., Giuliana G., and Gualtiero P. High plasma levels of factor VIII and risk of recurrence of venous thromboembolism. Br J Haematol 124 (2004) 504-510
-
(2004)
Br J Haematol
, vol.124
, pp. 504-510
-
-
Cristina, L.1
Benilde, C.2
Michela, C.3
Mirella, F.4
Giuliana, G.5
Gualtiero, P.6
-
32
-
-
0030860570
-
Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use
-
Lowe G.D., Rumley A., Woodward M., Morrison C.E., Philippou H., Lane D.A., et al. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol 97 (1997) 775-784
-
(1997)
Br J Haematol
, vol.97
, pp. 775-784
-
-
Lowe, G.D.1
Rumley, A.2
Woodward, M.3
Morrison, C.E.4
Philippou, H.5
Lane, D.A.6
-
33
-
-
0033042108
-
Activated protein C resistance and the FV:R506Q mutation in a random population sample-associations with cardiovascular risk factors and coagulation variables
-
Lowe G.D., Rumley A., Woodward M., Reid E., and Rumley J. Activated protein C resistance and the FV:R506Q mutation in a random population sample-associations with cardiovascular risk factors and coagulation variables. Thromb Haemost 81 (1999) 918-924
-
(1999)
Thromb Haemost
, vol.81
, pp. 918-924
-
-
Lowe, G.D.1
Rumley, A.2
Woodward, M.3
Reid, E.4
Rumley, J.5
-
34
-
-
0035679185
-
Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism
-
O'Donnell J., Mumford A.D., Manning R.A., and Laffan M.A. Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism. Br J Haematol 115 (2001) 687-691
-
(2001)
Br J Haematol
, vol.115
, pp. 687-691
-
-
O'Donnell, J.1
Mumford, A.D.2
Manning, R.A.3
Laffan, M.A.4
-
35
-
-
0034907754
-
Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein-a cross-sectional population survey
-
Lowe G.D., Upton M.N., Rumley A., McConnachie A., O'Reilly D.S., and Watt G.C. Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein-a cross-sectional population survey. Thromb Haemost 86 (2001) 550-556
-
(2001)
Thromb Haemost
, vol.86
, pp. 550-556
-
-
Lowe, G.D.1
Upton, M.N.2
Rumley, A.3
McConnachie, A.4
O'Reilly, D.S.5
Watt, G.C.6
-
37
-
-
0034099043
-
High levels of coagulation factor XI as a risk factor for venous thrombosis
-
Meijers J.C.M., Tekelenburg W.L.H., Bouma B.N., Bertina R.M., and Rosendaal F.R. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 342 (2000) 696-701
-
(2000)
N Engl J Med
, vol.342
, pp. 696-701
-
-
Meijers, J.C.M.1
Tekelenburg, W.L.H.2
Bouma, B.N.3
Bertina, R.M.4
Rosendaal, F.R.5
-
38
-
-
0036241283
-
Recurrent leg ulcers in a young man with hyperhomocysteinemia, factor V Leiden and impaired fibrinolysis
-
Kolbach D.N., Veraart J.C.J.M., Hamulyak K., Spaapen L.J.M., and Neumann H.A.M. Recurrent leg ulcers in a young man with hyperhomocysteinemia, factor V Leiden and impaired fibrinolysis. Acta Derm Venereol 82 (2002) 52-54
-
(2002)
Acta Derm Venereol
, vol.82
, pp. 52-54
-
-
Kolbach, D.N.1
Veraart, J.C.J.M.2
Hamulyak, K.3
Spaapen, L.J.M.4
Neumann, H.A.M.5
-
39
-
-
37549054652
-
Leg ulcers associated with factor V Leiden and prothrombin G20210A and methyltetrahydrofolate reductase mutations: successful treatment with warfarin
-
Brandt H.R.C., Messina M.C.D., Belda Jr. W., Martins J.E.C., and Criado P.R. Leg ulcers associated with factor V Leiden and prothrombin G20210A and methyltetrahydrofolate reductase mutations: successful treatment with warfarin. Int J Dermatol 46 (2007) 1319-1320
-
(2007)
Int J Dermatol
, vol.46
, pp. 1319-1320
-
-
Brandt, H.R.C.1
Messina, M.C.D.2
Belda Jr., W.3
Martins, J.E.C.4
Criado, P.R.5
-
40
-
-
0035141397
-
Stasis ulcers refractory to therapy-accelerated healing by treatment with clopidogrel +/- dalteparin: a preliminary report
-
Bick R.L., and Scott R.G. Stasis ulcers refractory to therapy-accelerated healing by treatment with clopidogrel +/- dalteparin: a preliminary report. Clin Appl Thromb Hemost 7 (2001) 21-24
-
(2001)
Clin Appl Thromb Hemost
, vol.7
, pp. 21-24
-
-
Bick, R.L.1
Scott, R.G.2
|